287 related articles for article (PubMed ID: 35863000)
1. Combing Immunoinformatics with Pangenome Analysis To Design a Multiepitope Subunit Vaccine against Klebsiella pneumoniae K1, K2, K47, and K64.
Wang Z; Guo G; Li Q; Li P; Li M; Zhou L; Tan Z; Zhang W
Microbiol Spectr; 2022 Aug; 10(4):e0114822. PubMed ID: 35863000
[TBL] [Abstract][Full Text] [Related]
2. Characterization difference of typical KL1, KL2 and ST11-KL64 hypervirulent and carbapenem-resistant Klebsiella pneumoniae.
Zhou Y; Wu C; Wang B; Xu Y; Zhao H; Guo Y; Wu X; Yu J; Rao L; Wang X; Yu F
Drug Resist Updat; 2023 Mar; 67():100918. PubMed ID: 36610180
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Epidemiology of Prevalent Klebsiella pneumoniae Strains and Humoral Antibody Responses against Carbapenem-Resistant K. pneumoniae Infections among Pediatric Patients in Shanghai.
Wang J; Ma R; Pan F; Wu Y; Pan Y; Liu Y; Yu F; Yu J; Lun H; Shi Y; Zhang H; He P
mSphere; 2022 Oct; 7(5):e0027122. PubMed ID: 36069436
[TBL] [Abstract][Full Text] [Related]
4. Hypervirulent carbapenem-resistant
Huang N; Jia H; Zhou B; Zhou C; Cao J; Liao W; Liu S; Wang L; Chen L; Chen L; Zhou T; Ye J
Front Public Health; 2022; 10():991306. PubMed ID: 36324461
[No Abstract] [Full Text] [Related]
5. Multiplex PCR Analysis for Rapid Detection of Klebsiella pneumoniae Carbapenem-Resistant (Sequence Type 258 [ST258] and ST11) and Hypervirulent (ST23, ST65, ST86, and ST375) Strains.
Yu F; Lv J; Niu S; Du H; Tang YW; Pitout JDD; Bonomo RA; Kreiswirth BN; Chen L
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29925644
[TBL] [Abstract][Full Text] [Related]
6. Emergence of ST11-K47 and ST11-K64 hypervirulent carbapenem-resistant
Yang Q; Jia X; Zhou M; Zhang H; Yang W; Kudinha T; Xu Y
Emerg Microbes Infect; 2020; 9(1):320-331. PubMed ID: 32037975
[No Abstract] [Full Text] [Related]
7. Identification and Characterization of NDM-1-producing Hypervirulent (Hypermucoviscous)
Liu Z; Gu Y; Li X; Liu Y; Ye Y; Guan S; Li J
Ann Lab Med; 2019 Mar; 39(2):167-175. PubMed ID: 30430779
[TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical characterization of hypervirulent
Li J; Tang M; Liu Z; Xia F; Min C; Hu Y; Wang H; Zou M
Front Cell Infect Microbiol; 2022; 12():925440. PubMed ID: 36004330
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics.
Su S; Zhang J; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Li C; Zhang X
BMC Infect Dis; 2020 Jul; 20(1):472. PubMed ID: 32616018
[TBL] [Abstract][Full Text] [Related]
10. The emergence of the hypervirulent Klebsiella pneumoniae (hvKp) strains among circulating clonal complex 147 (CC147) harbouring bla
Pajand O; Darabi N; Arab M; Ghorbani R; Bameri Z; Ebrahimi A; Hojabri Z
Ann Clin Microbiol Antimicrob; 2020 Mar; 19(1):12. PubMed ID: 32234050
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of Plasmid with Carbapenem-Resistance Gene bla
Chen Y; Marimuthu K; Teo J; Venkatachalam I; Cherng BPZ; De Wang L; Prakki SRS; Xu W; Tan YH; Nguyen LC; Koh TH; Ng OT; Gan YH
Emerg Infect Dis; 2020 Mar; 26(3):549-559. PubMed ID: 32091354
[TBL] [Abstract][Full Text] [Related]
12. Investigations of carbapenem resistant and hypervirulent Klebsiella pneumoniae.
Belouad EM; Benaissa E; El Mrimar N; Eddair Y; Maleb A; Elouennass M
Acta Microbiol Immunol Hung; 2024 Mar; 71(1):52-60. PubMed ID: 38289372
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Hypervirulent ST11-K64
Wei T; Zou C; Qin J; Tao J; Yan L; Wang J; Du H; Shen F; Zhao Y; Wang H
Front Public Health; 2022; 10():765624. PubMed ID: 35309213
[TBL] [Abstract][Full Text] [Related]
14. Hypervirulent Capsular Serotypes K1 and K2
Al-Busaidi B; Al-Muzahmi M; Al-Shabibi Z; Rizvi M; Al-Rashdi A; Al-Jardani A; Farzand R; Al-Jabri Z
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339222
[TBL] [Abstract][Full Text] [Related]
15. A 20-Year Study of Capsular Polysaccharide Seroepidemiology, Susceptibility Profiles, and Virulence Determinants of Klebsiella pneumoniae from Bacteremia Patients in Taiwan.
Tsai CC; Lin JC; Chen PC; Liu EY; Tsai YK; Yu CP; Li JJ; Wang CH; Fung CP; Lin FM; Chang FY; Siu LK
Microbiol Spectr; 2023 Jun; 11(3):e0035923. PubMed ID: 37191538
[TBL] [Abstract][Full Text] [Related]
16. A promising bioconjugate vaccine against hypervirulent
Feldman MF; Mayer Bridwell AE; Scott NE; Vinogradov E; McKee SR; Chavez SM; Twentyman J; Stallings CL; Rosen DA; Harding CM
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18655-18663. PubMed ID: 31455739
[TBL] [Abstract][Full Text] [Related]
17. Hypervirulent Klebsiella pneumoniae serotype K1 clinical isolates form robust biofilms at the air-liquid interface.
Cubero M; Marti S; Domínguez MÁ; González-Díaz A; Berbel D; Ardanuy C
PLoS One; 2019; 14(9):e0222628. PubMed ID: 31532800
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem Resistance Conferred by OXA-48 in K2-ST86 Hypervirulent Klebsiella pneumoniae, France.
Beyrouthy R; Dalmasso G; Birer A; Robin F; Bonnet R
Emerg Infect Dis; 2020 Jul; 26(7):1529-1533. PubMed ID: 32568057
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China.
Li J; Huang ZY; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
BMC Microbiol; 2019 Sep; 19(1):219. PubMed ID: 31533609
[TBL] [Abstract][Full Text] [Related]
20. A 24-year longitudinal study of
Kao CY; Zhang YZ; Bregente CJB; Kuo PY; Chen PK; Chao JY; Duong TTT; Wang MC; Thuy TTD; Hidrosollo JH; Tsai PF; Li YC; Lin WH
Epidemiol Infect; 2023 Sep; 151():e155. PubMed ID: 37675569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
